Schizophrenia

Schizophrenia is a chronic debilitating disorder which affects more than two million Americans, and millions more worldwide. While significant progress has been made in understanding the disease and developing treatments, there remains a significant unmet medical need. More than 50% of patients switch their medication in a given year due to either poor response or the experience of adverse events.
Schizophrenia

Schizophrenia is a chronic mental health disorder that causes people to think, feel and perceive the world differently from the general population.

Read More

Overview

Feature Articles

Latest Schizophrenia News and Research

Scientists discover IC–encoder neurons that shape visual perception

Scientists discover IC–encoder neurons that shape visual perception

Mentavi study validates first fully digital diagnostic pathway for adult ADHD

Mentavi study validates first fully digital diagnostic pathway for adult ADHD

Detecting causality in neural spike trains using a new technique

Detecting causality in neural spike trains using a new technique

Rapid neuronal evolution linked to high prevalence of autism in humans

Rapid neuronal evolution linked to high prevalence of autism in humans

Study finds sex differences in schizophrenia and bipolar disorder

Study finds sex differences in schizophrenia and bipolar disorder

First complete brain activity map reveals how decisions are made

First complete brain activity map reveals how decisions are made

Cardiovascular outcomes worsen in patients with mental health conditions

Cardiovascular outcomes worsen in patients with mental health conditions

Targeting gut signaling protein may protect against alcohol-related liver damage

Targeting gut signaling protein may protect against alcohol-related liver damage

Specialized neurons in mice influence social attention and empathy

Specialized neurons in mice influence social attention and empathy

People with schizophrenia are more likely to develop COPD

People with schizophrenia are more likely to develop COPD

Mitochondrial dysfunction in the blood-brain barrier may contribute to neuropsychiatric disease in 22qDS

Mitochondrial dysfunction in the blood-brain barrier may contribute to neuropsychiatric disease in 22qDS

Patients recall inadequate disclosure of electroconvulsive therapy risks

Patients recall inadequate disclosure of electroconvulsive therapy risks

Love hormone oxytocin found to be critical for the formation of friendships

Love hormone oxytocin found to be critical for the formation of friendships

Scientists reveal how rare gene mutations drive schizophrenia risk

Scientists reveal how rare gene mutations drive schizophrenia risk

Mapping the brain’s serotonin switch could lead to better antidepressants

Mapping the brain’s serotonin switch could lead to better antidepressants

Groundbreaking Living Brain Project challenges decades of assumptions in neuroscience

Groundbreaking Living Brain Project challenges decades of assumptions in neuroscience

Mexican neuroscientist's journey from exile to schizophrenia research breakthroughs

Mexican neuroscientist's journey from exile to schizophrenia research breakthroughs

Scientists uncover new brain mechanism driving PTSD and potential counter-drug

Scientists uncover new brain mechanism driving PTSD and potential counter-drug

Uncovering origins of autism, depression, Parkinson's in fetal brain

Uncovering origins of autism, depression, Parkinson's in fetal brain

Automated cage monitoring system reveals behavioral changes in schizophrenia mouse model

Automated cage monitoring system reveals behavioral changes in schizophrenia mouse model

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.